CCN2 and myelofibrosis: This difference did not reach statistical significance (p = 0.28), but the mean percentage of CCN2-positive megakaryocytes was significantly higher in myelofibrosis patients at diagnosis (63%) compared to post-transplant biopsies 22% [13].